Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575308
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBAlnylam PharmaceuticalsNot Yet RecruitingPhase 2
NCT07575308Not Yet Recruiting
Phase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Pa...Alnylam Pharmaceuticals
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut UniversityCompleted
NCT07575243Completed
—
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) ProtocolAssiut University
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07576608
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Bioscience Co., Ltd.RecruitingPhase 2
NCT07576608Recruiting
Phase 2
A Phase II Study of 9MW3811 in Patients With Pathological ScarMabwell (Shanghai) Biosci...
NCT07576387
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare HamiltonNot Yet RecruitingNot Applicable
NCT07576387Not Yet Recruiting
Not Applicable
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)St. Joseph's Healthcare H...
NCT07576283
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training in PostpartumRiphah International UniversityRecruitingNot Applicable
NCT07576283Recruiting
Not Applicable
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Train...Riphah International Univ...
NCT07574710
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability in Immediate Implant Placement: A Clinical Study With 1-Year Post-Restorative ResultsTomas LinkeviciusCompletedNot Applicable
NCT07574710Completed
Not Applicable
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability...Tomas Linkevicius
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575152
Estimation of Fetal Weight by Measuring Abdominal Circumference, Abdominal Subcutaneous Soft Tissue Thickness, Femur Length and Mid-thigh Soft Tissue Thickness: Cross Sectional Study.Assiut UniversityNot Yet Recruiting
NCT07575152Not Yet Recruiting
—
Estimation of Fetal Weight by Measuring Abdominal Circumference, Abdominal Subcu...Assiut University
NCT07574905
Evaluation of Satisfaction and Experiences in Patients Undergoing Awake Intubation.Hacettepe UniversityRecruiting
NCT07574905Recruiting
—
Evaluation of Satisfaction and Experiences in Patients Undergoing Awake Intubati...Hacettepe University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575750
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double BlindInstitut Cancerologie de l'OuestNot Yet RecruitingNot Applicable
NCT07575750Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatas...Institut Cancerologie de...
NCT07575373
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Intervention to Improve Transitions to Follow-Up Care for Hospitalized Patients With Substance Use DisordersMichael InczeNot Yet RecruitingNot Applicable
NCT07575373Not Yet Recruiting
Not Applicable
Evaluating the Feasibility of an Interdisciplinary Primary Care-based Interventi...Michael Incze
NCT07575919
Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALLLiping DouRecruitingPhase 1
NCT07575919Recruiting
Phase 1
Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALLLiping Dou
Result Breakdown
Not yet recruiting9 (45%)
Recruiting8 (40%)
Completed3 (15%)
not_applicable10 (50%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 12 (10%)